Table 3.
Multilevel logistic regression of patient satisfaction (OR with 95% confidence interval).
| Specification | Administrative process | Hospital environment | Medical care | Symptom managementa | Overall satisfaction | |
|---|---|---|---|---|---|---|
| Sex | Female | 1 [Reference] | 1 [Reference] | 1 [Reference] | 1 [Reference] | 1 [Reference] |
| Male |
0.73 (0.61, 0.87)*** |
0.90 (0.75, 1.09) |
0.76 (0.60, 0.96)* |
0.93 (0.74, 1.16) |
0.88 (0.73, 1.06) |
|
| Age | 18–45 | 1 [Reference] | 1 [Reference] | 1 [Reference] | 1 [Reference] | 1 [Reference] |
| 45–64 | 1.19 (0.98, 1.45) |
1.40 (1.14, 1.73)*** |
1.19 (0.91, 1.55) |
1.13 (0.87, 1.45) |
1.13 (0.92, 1.39) |
|
| 65–85 | 1.09 (0.85, 1.39) |
1.11 (0.86, 1.45) |
0.91 (0.66, 1.27) |
1.10 (0.79, 1.52) |
1.01 (0.78, 1.32) |
|
| Education | College or above | 1 [Reference] | 1 [Reference] | 1 [Reference] | 1 [Reference] | 1 [Reference] |
| Junior or high school | 1.02 (0.84, 1.25) |
1.04 (0.84, 1.29) |
0.96 (0.74, 1.27) |
1.12 (0.87, 1.44) |
0.92 (0.74, 1.14) |
|
| Primary School or less | 0.91 (0.70, 1.19) |
0.89 (0.67, 1.18) |
0.72 (0.51, 1.02) |
1.06 (0.76, 1.49) |
0.80 (0.60, 1.06) |
|
| Monthly family income | <30,000 | 1 [Reference] | 1 [Reference] | 1 [Reference] | 1 [Reference] | 1 [Reference] |
| 30,000–60,000 | 0.92 (0.76, 1.11) |
0.92 (0.75, 1.13) |
1.06 (0.82, 1.36) |
0.94 (0.73, 1.20) |
1.03 (0.84, 1.26) |
|
| ≥60,000 | 1.15 (0.93, 1.43) |
1.08 (0.86, 1.36) |
1.12 (0.84, 1.49) |
1.04 (0.79, 1.37) |
1.11 (0.88, 1.39) |
|
| Cancer type | Lung cancer |
0.63 (0.50, 0.80)*** |
0.82 (0.63, 1.06) |
0.75 (0.54, 1.06) |
0.73 (0.54, 0.98)* |
0.75 (0.58, 0.98)* |
| Digestive tract cancer (esophagus, gastric, colorectal) | 0.89 (0.71, 1.11) |
0.96 (0.76, 1.22) |
0.84 (0.61, 1.15) |
0.77 (0.58, 1.02) |
0.91 (0.72, 1.16) |
|
| Breast or cervical cancer |
0.56 (0.44, 0.72)*** |
0.78 (0.60, 1.02) |
0.49 (0.35, 0.68)*** |
0.54 (0.40, 0.74)*** |
0.64 (0.49, 0.83)*** |
|
| Other types | 1 [Reference] | 1 [Reference] | 1 [Reference] | 1 [Reference] | 1 [Reference] | |
| Non-cancer | 1.07 (0.80, 1.43) |
1.21 (0.89, 1.64) |
1.01 (0.69, 1.47) |
1.17 (0.76, 1.79) |
1.22 (0.90, 1.65) |
|
| Cancer stage | 0–2 | 1 [Reference] | 1 [Reference] | 1 [Reference] | 1 [Reference] | 1 [Reference] |
| 3–4 | 0.92 (0.75, 1, 14) |
1.10 (0.88, 1.38) |
1.28 (0.95, 1.71) |
0.93 (0.72, 1.19) |
1.13 (0.90, 1.42) |
|
| unknown |
0.81 (0.65, 0.99)* |
0.79 (0.63, 0.99)* |
0.80 (0.61, 1.06) |
0.66 (0.51, 0.87)** |
0.70 (0.56, 0.87)*** |
|
| Self-reported health status | Worse | 1 [Reference] | 1 [Reference] | 1 [Reference] | 1 [Reference] | 1 [Reference] |
| Moderate | 1.03 (0.86, 1.24) |
1.15 (0.95, 1.39) |
0.99 (0.78, 1.26) |
1.09 (0.87, 1.36) |
1.06 (0.88, 1.28) |
|
| Better | 1.14 (0.94, 1.39) |
1.55 (1.25, 1.92)*** |
1.25 (0.95, 1.64) |
1.52 (1.16, 1.99)** |
1.60 (1.29, 1.99)*** |
|
| Length of stay | 1–14 days | 1 [Reference] | 1 [Reference] | 1 [Reference] | 1 [Reference] | 1 [Reference] |
| >14 days | 0.86 (0.72, 1.03) |
0.91 (0.75, 1.11) |
0.85 (0.67, 1.08) |
0.83 (0.66, 1.04) |
0.99 (0.81, 1.21) |
|
| Respondent | Patient | 1 [Reference] | 1 [Reference] | 1 [Reference] | 1 [Reference] | 1 [Reference] |
| Representative |
0.82 (0.69, 0.98)* |
0.80 (0.66, 0.97)* |
1.07 (0.84, 1.36) |
0.76 (0.61, 0.95)* |
0.88 (0.73, 1.07) |
|
| ICC(%)b | 0.108 (0.063, 0.181) |
0.155 (0.093, 0.247) |
0.161 (0.092, 0.265) |
0.069 (0.034, 0.136) |
0.144 (0.084, 0.235) |
|
a
Sample size of symptom management was 2,276 because not all patients had undergone clinical symptoms surveyed.
*
P < 0.05,
**
P < 0.01,
***
P < 0.001.
b
Represent ICC and its 95%confidence interval after case-mix adjustment. Bold OR with 95% confidence interval is beyond or below 1.
ICC, intraclass correlation coefficient.